Randomized Study of Acetylcysteine in Patients With Acute Liver Failure Not Caused by Acetaminophen
- Registration Number
- NCT00004467
- Brief Summary
OBJECTIVES:
I. Determine the safety and efficacy of a short course (72 hours) of intravenous acetylcysteine in patients with acute liver failure for whom no antidote or specific treatment is available.
- Detailed Description
PROTOCOL OUTLINE: This is a randomized, multicenter study. Patients are randomized to receive intravenous acetylcysteine or placebo for 72 hours. Treatment must begin within 12 hours of hospitalization. Patients who advance to grade III or IV encephalopathy are eligible for liver transplantation.
Patients are followed at 3 weeks.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 173
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description N-acetylcysteine (NAC) N-acetylcysteine (NAC) - Placebo Placebo -
- Primary Outcome Measures
Name Time Method Overall survival rate 3 weeks
- Secondary Outcome Measures
Name Time Method Survival without liver transplantation (Spontaneous Survival 3 weeks Number of organ systems showing failure 3 weeks Transplant rate 3 weeks Length of hospital stay 3 weeks
Trial Locations
- Locations (23)
Massachusetts General Hospital
🇺🇸Boston, Massachusetts, United States
University of Washington Medical Center
🇺🇸Seattle, Washington, United States
University of California Los Angeles
🇺🇸Los Angeles, California, United States
Northwestern University Medical School
🇺🇸Chicago, Illinois, United States
Washington University School of Medicine
🇺🇸Saint Louis, Missouri, United States
Mount Sinai Medical Center, NY
🇺🇸New York, New York, United States
University of Pennsylvania
🇺🇸Philadelphia, Pennsylvania, United States
Albert Einstein Medical Center
🇺🇸Philadelphia, Pennsylvania, United States
University of Pittsburgh Medical Center
🇺🇸Pittsburgh, Pennsylvania, United States
University of Texas Southwestern Medical Center at Dallas
🇺🇸Dallas, Texas, United States
University of California San Diego
🇺🇸San Diego, California, United States
University of California San Francisco
🇺🇸San Francisco, California, United States
Duke University Medical Center
🇺🇸Durham, North Carolina, United States
Baylor University Medical Center
🇺🇸Dallas, Texas, United States
New York Presbyterian Hospital
🇺🇸New York, New York, United States
Oregon Health Sciences University
🇺🇸Portland, Oregon, United States
University of Alabama at Birmingham
🇺🇸Birmingham, Alabama, United States
Mayo Clinic
🇺🇸Rochester, Minnesota, United States
University of California Davis
🇺🇸Sacramento, California, United States
University of Michigan Health Systems
🇺🇸Ann Arbor, Michigan, United States
Virginia Commonwealth University
🇺🇸Richmond, Virginia, United States
University of Nebraska Medical Center
🇺🇸Omaha, Nebraska, United States
Medical University of South Carolina
🇺🇸Charleston, South Carolina, United States